Thymic self-reactivity selects natural interleukin 17-producing T cells that can regulate peripheral inflammation

被引:146
作者
Marks, Benjamin R. [1 ]
Nowyhed, Heba N. [1 ]
Choi, Jin-Young [2 ]
Poholek, Amanda C. [3 ]
Odegard, Jared M. [1 ]
Flavell, Richard A. [1 ,4 ]
Craft, Joe [1 ,2 ]
机构
[1] Yale Univ, Sch Med, Dept Immunol, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Dept Internal Med, Rheumatol Sect, New Haven, CT 06510 USA
[3] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA
[4] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA
关键词
ROR-GAMMA-T; TGF-BETA; AUTOIMMUNE ENCEPHALOMYELITIS; CUTTING EDGE; TH17; CELLS; NKT CELLS; DIFFERENTIATION; LINEAGE; DISEASE; ANTIGEN;
D O I
10.1038/ni.1783
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interleukin 17 (IL-17)-producing CD4(+) helper T cells (T-H-17 cells) share a developmental relationship with Foxp3(+) regulatory T cells (T-reg cells). Here we show that a T-H-17 population differentiates in the thymus in a manner influenced by recognition of self antigen and by the cytokines IL-6 and transforming growth factor-beta (TGF-beta). Like previously described T-H-17 cells, the T-H-17 cells that developed in the thymus expressed the transcription factor ROR gamma t and the IL-23 receptor. These cells also expressed alpha(4)beta(1) integrins and the chemokine receptor CCR6 and were recruited to the lung, gut and liver. In the liver, these cells secreted IL-22 in response to self antigen and mediated host protection during inflammation. Thus, T-H-17 cells, like T-reg cells, can be selected by self antigens in the thymus.
引用
收藏
页码:1125 / U108
页数:9
相关论文
共 53 条
[1]   Functional diversity of helper T lymphocytes [J].
Abbas, AK ;
Murphy, KM ;
Sher, A .
NATURE, 1996, 383 (6603) :787-793
[2]   Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17 [J].
Aggarwal, S ;
Ghilardi, N ;
Xie, MH ;
de Sauvage, FJ ;
Gurney, AL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (03) :1910-1914
[3]   Acinar cells of the pancreas are a target of interleukin-22 [J].
Aggarwal, S ;
Xie, MH ;
Maruoka, M ;
Foster, J ;
Gurney, AL .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2001, 21 (12) :1047-1053
[4]   Origin of regulatory T cells with known specificity for antigen [J].
Apostolou, I ;
Sarukhan, A ;
Klein, L ;
von Boehmer, H .
NATURE IMMUNOLOGY, 2002, 3 (08) :756-763
[5]   A20 protects mice from D-galactosamine/lipopolysaccharide acute toxic lethal hepatitis [J].
Arvelo, MB ;
Cooper, JT ;
Longo, C ;
Daniel, S ;
Grey, ST ;
Mahiou, J ;
Czismadia, E ;
Abu-Jawdeh, G ;
Ferran, C .
HEPATOLOGY, 2002, 35 (03) :535-543
[6]  
Betti M, 2006, ANN ONCOL, V17, P235
[7]   Rationale and safety of anti-interleukin-23 and anti-interieukin-17A therapy [J].
Bowman, Edward P. ;
Chackerian, Alissa A. ;
Cua, Daniel J. .
CURRENT OPINION IN INFECTIOUS DISEASES, 2006, 19 (03) :245-252
[8]   Starting at the beginning: New perspectives on the biology of mucosal T cells [J].
Cheroutre, H .
ANNUAL REVIEW OF IMMUNOLOGY, 2004, 22 :217-246
[9]   Antigen recognition by γδ T cells [J].
Chien, Yueh-Hsiu ;
Konigshofer, Yves .
IMMUNOLOGICAL REVIEWS, 2007, 215 :46-58
[10]   T cells that cannot respond to TGF-β escape control by CD4+CD25+ regulatory T cells [J].
Fahlén, L ;
Read, S ;
Gorelik, L ;
Hurst, SD ;
Coffman, RL ;
Flavell, RA ;
Powrie, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (05) :737-746